Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 1
1981 1
1984 2
1985 3
1986 4
1987 1
1988 1
1989 1
1990 2
1991 3
1993 3
1994 9
1995 10
1996 6
1997 2
1998 6
1999 6
2000 1
2001 1
2003 6
2004 7
2005 4
2006 9
2007 10
2008 12
2009 16
2010 18
2011 20
2012 21
2013 22
2014 23
2015 26
2016 9
2017 8
2018 13
2019 9
2020 5
2021 5
2022 2
2023 1

Text availability

Article attribute

Article type

Publication date

Search Results

271 results

Results by year

Filters applied: . Clear all
Page 1
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force.
Smolen JS, Breedveld FC, Burmester GR, Bykerk V, Dougados M, Emery P, Kvien TK, Navarro-Compán MV, Oliver S, Schoels M, Scholte-Voshaar M, Stamm T, Stoffer M, Takeuchi T, Aletaha D, Andreu JL, Aringer M, Bergman M, Betteridge N, Bijlsma H, Burkhardt H, Cardiel M, Combe B, Durez P, Fonseca JE, Gibofsky A, Gomez-Reino JJ, Graninger W, Hannonen P, Haraoui B, Kouloumas M, Landewe R, Martin-Mola E, Nash P, Ostergaard M, Östör A, Richards P, Sokka-Isler T, Thorne C, Tzioufas AG, van Vollenhoven R, de Wit M, van der Heijde D. Smolen JS, et al. Among authors: gomez reino jj. Ann Rheum Dis. 2016 Jan;75(1):3-15. doi: 10.1136/annrheumdis-2015-207524. Epub 2015 May 12. Ann Rheum Dis. 2016. PMID: 25969430 Free PMC article. Review.
Malignancy risk with tofacitinib versus TNF inhibitors in rheumatoid arthritis: results from the open-label, randomised controlled ORAL Surveillance trial.
Curtis JR, Yamaoka K, Chen YH, Bhatt DL, Gunay LM, Sugiyama N, Connell CA, Wang C, Wu J, Menon S, Vranic I, Gómez-Reino JJ. Curtis JR, et al. Among authors: gomez reino jj. Ann Rheum Dis. 2023 Mar;82(3):331-343. doi: 10.1136/ard-2022-222543. Epub 2022 Dec 5. Ann Rheum Dis. 2023. PMID: 36600185 Free PMC article. Clinical Trial.
Efficacy of Tocilizumab in Patients With Moderate-to-Severe Corticosteroid-Resistant Graves Orbitopathy: A Randomized Clinical Trial.
Perez-Moreiras JV, Gomez-Reino JJ, Maneiro JR, Perez-Pampin E, Romo Lopez A, Rodríguez Alvarez FM, Castillo Laguarta JM, Del Estad Cabello A, Gessa Sorroche M, España Gregori E, Sales-Sanz M; Tocilizumab in Graves Orbitopathy Study Group. Perez-Moreiras JV, et al. Among authors: gomez reino jj. Am J Ophthalmol. 2018 Nov;195:181-190. doi: 10.1016/j.ajo.2018.07.038. Epub 2018 Aug 4. Am J Ophthalmol. 2018. PMID: 30081019 Clinical Trial.
Abatacept for the treatment of rheumatoid arthritis.
Pombo-Suarez M, Gomez-Reino JJ. Pombo-Suarez M, et al. Among authors: gomez reino jj. Expert Rev Clin Immunol. 2019 Apr;15(4):319-326. doi: 10.1080/1744666X.2019.1579642. Epub 2019 Feb 18. Expert Rev Clin Immunol. 2019. PMID: 30730220 Review.
An update on leptin as immunomodulator.
Conde J, Scotece M, Abella V, López V, Pino J, Gómez-Reino JJ, Gualillo O. Conde J, et al. Among authors: gomez reino jj. Expert Rev Clin Immunol. 2014 Sep;10(9):1165-70. doi: 10.1586/1744666X.2014.942289. Epub 2014 Aug 7. Expert Rev Clin Immunol. 2014. PMID: 25098336 Review.
Visfatin as a therapeutic target for rheumatoid arthritis.
Franco-Trepat E, Alonso-Pérez A, Guillán-Fresco M, Jorge-Mora A, Gualillo O, Gómez-Reino JJ, Gómez Bahamonde R. Franco-Trepat E, et al. Among authors: gomez reino jj. Expert Opin Ther Targets. 2019 Jul;23(7):607-618. doi: 10.1080/14728222.2019.1617274. Epub 2019 May 15. Expert Opin Ther Targets. 2019. PMID: 31074669 Review.
Apremilast for the treatment of psoriatic arthritis.
Souto A, Gómez-Reino JJ. Souto A, et al. Among authors: gomez reino jj. Expert Rev Clin Immunol. 2015;11(12):1281-90. doi: 10.1586/1744666X.2015.1102057. Epub 2015 Oct 26. Expert Rev Clin Immunol. 2015. PMID: 26503917 Review.
Predictors of response to TNF antagonists.
Salgado E, Maneiro JR, Gomez-Reino JJ. Salgado E, et al. Among authors: gomez reino jj. Curr Pharm Des. 2015;21(2):221-32. doi: 10.2174/1381612820666140825124152. Curr Pharm Des. 2015. PMID: 25163737 Review.
Adipokines: novel players in rheumatic diseases.
Conde J, Scotece M, López V, Gómez R, Lago F, Pino J, Gómez-Reino JJ, Gualillo O. Conde J, et al. Among authors: gomez reino jj. Discov Med. 2013 Feb;15(81):73-83. Discov Med. 2013. PMID: 23449109 Free article. Review.
Adipokines, metabolic syndrome and rheumatic diseases.
Abella V, Scotece M, Conde J, López V, Lazzaro V, Pino J, Gómez-Reino JJ, Gualillo O. Abella V, et al. Among authors: gomez reino jj. J Immunol Res. 2014;2014:343746. doi: 10.1155/2014/343746. Epub 2014 Feb 26. J Immunol Res. 2014. PMID: 24741591 Free PMC article. Review.
271 results